“IMPACT OF GLP-1 RECEPTOR AGONISTS ON LIVER ENZYMES AND FIBROSIS SCORES IN TYPE 2 DIABETIC AND NON-DIABETIC PATIENTS WITH FATTY LIVER DISEASE”. 2026. Frontier in Medical and Health Research 4 (3): 4646-54. https://fmhr.net/index.php/fmhr/article/view/3859.